Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-11

Clinical Trial Update: Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluated omega-3 fatty acids for immune effects in kidney transplant patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Kidney Diseases | EARLY_Phase 1 | Status: COMPLETED